Actor
AlphaOnco Swiss SA
AlphaOnco Swiss, subsidiary of Nanobacterie, is developing a cancer treatment using natural iron oxide nano-minerals, called magnetosomes, which are introduced to tumors and heated using various excitation sources (laser, ultrasound, magnetic field).
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Oncology
Main sector
Biotech
Contact
Rte de l’Ile-au-bois 1A
1870 Monthey / VS
+33 6 32 69 70 20